University of Cambridge > Talks.cam > Cambridge Immunology Network Seminar Series > Defining “at risk states”: molecular pathways and clinical phenotypes associated with rheumatoid arthritis.

Defining “at risk states”: molecular pathways and clinical phenotypes associated with rheumatoid arthritis.

Add to your list(s) Download to your calendar using vCal

If you have a question about this talk, please contact Dr. Maryam Arasteh.

Andrew Cope, King’s College London. Hosted by Ken Smith.

Abstract not available

This talk is part of the Cambridge Immunology Network Seminar Series series.

Tell a friend about this talk:

This talk is included in these lists:

Note that ex-directory lists are not shown.

 

© 2006-2024 Talks.cam, University of Cambridge. Contact Us | Help and Documentation | Privacy and Publicity